As Beth Israel Deaconess Medical Center's (BIDMC) technology transfer organization, the Technology Ventures Office (TVO) serves as a bridge between our medical center's faculty and the business community.
TVO's technically trained and business-oriented professionals work with biomedical companies, venture capitalists, and entrepreneurs to find the best way to transfer BIDMC inventions and innovative knowledge to commercial partners.
The mission of the Technology Ventures Office (TVO) is to promote public utilization of Beth Israel Deaconess Medical Center (BIDMC) technologies for society’s use and benefit, and to foster alliances with industry through collaboration and licensing agreements, while generating unrestricted income to support research at our institution.
We work with biomedical companies, venture capitalists, and entrepreneurs to find the best way to commercialize new technologies and to promote corporate collaborations that can increase our level of industrial support for research.
Role: Associate Director
The Technology Ventures Office (TVO) database contains a selected list of available technologies from Beth Israel Deaconess Medical Center. The database is periodically updated with new technologies for bioinformatics, diagnostics and biomarkers, drug delivery and drug discovery tools, medical devices, medical imaging, research reagents, and therapeutics. If you would like additional information, please feel free to contact the Technology Ventures Office of Beth Israel Deaconess Medical Center.
"The Technology Ventures Office (TVO) evaluates, patents, markets, and licenses BIDMC faculty inventions.
TVO manages patent prosecution, and negotiates license, option, corporate sponsored research, material transfer, and confidentiality agreements.
TVO distributes royalty income derived from technology transfer among inventors, their laboratories, their departments, Research Fund, and the Medical Center’s general fund according to BIDMC policy."
"One of the missions of Beth Israel Deaconess Medical Center (BIDMC) is to facilitate the transfer of the results of BIDMC research to the benefit of society in partnership with other organizations, both for-profit and non-profit.
One objective of the Technology Ventures Office (TVO) is to encourage researchers to describe novel ideas, inventions, or biological materials that may have medical, research, and/or commercial uses. The purpose of this Invention and Technology Disclosure is to record an invention and related circumstances and to serve as the basis for an evaluation by the TVO of an invention's patentability and potential for commercial application."
"If you want to discuss your research ideas or share some confidential information with the industry, you would need a Confidentiality Agreement during the period a company or another institution is evaluating the idea or information. It is important to set-up a confidentiality agreement prior to the company meeting or company evaluation of your proprietary ideas. Please contact us for additional information."
"Material Transfer Agreements (MTAs) are contracts that govern the exchange of research reagents, such as biomaterials or drugs, between BIDMC and academic institutions or companies. These agreements often form the basis for future collaborations."
"Once a patent is filed, the Technology Ventures Office (TVO) markets the invention and negotiates a license agreement. The TVO also negotiates license agreements for non-patented research tools, such as reagents, software, and know-how. Please contact us for additional information."
"The Technology Ventures Office (TVO) at Beth Israel Deaconess Medical Center (BIDMC) speeds the development of our researchers' groundbreaking discoveries by fostering strategic collaborations with industry partners through sponsored research and licensing agreements."